Unity Biotechnology Names Federico Grossi Chief Medical …
3 days ago · Grossi had previously served as Chief Medical Officer at Apellis Pharmaceuticals. Friday, UBX had closed 12.28% higher at $1.28 on the Nasdaq. In the pre-market trading, UBX is 8.59% further ...
UNITY Biotechnology Announces Appointment of Federico Grossi…
3 days ago · SAN FRANCISCO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse diseases of aging ...
UNITY Biotechnology Reports Granting of New Employment …
1 day ago · SOUTH SAN FRANCISCO, Calif., Jan. 07, 2025 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse ...
UNITY Biotechnology Appoints Federico Grossi, M.D., Ph.D., as
3 days ago · UNITY Biotechnology has appointed Federico Grossi, M.D., Ph.D., as its new chief medical officer to enhance its leadership team. Dr. Grossi, who has over 20 years of experience in biotech ...
Unity Biotechnology Names Federico Grossi Chief Medical …
3 days ago · Shares of Unity Biotechnology, Inc. are gaining 9% in the pre-market trading after it has announced the appointment of Federico Grossi as Chief Medical Officer.Federico Grossi said he is looking forward to advance UBX1325, and advance pipeline to provide new and differentiated treatment options for patients with progressive retinal diseases.
UNITY Biotechnology Announces Appointment of Federico Grossi…
SAN FRANCISCO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse diseases of aging, today strengthened the executive leadership team with the appointment of Federico Grossi, M.D., Ph.D., as chief medical officer. Dr. Grossi brings a wealth of experience in clinical development and ...
UNITY Biotech appoints new chief medical officer - Investing.com
3 days ago · Dr. Grossi's academic credentials include an M.D. from the Universidad Nacional de Córdoba, Argentina, and M.S. and Ph.D. degrees from the University of Louisville.
UNITY Biotechnology Appoints Federico Grossi, M.D., Ph.D., as …
3 days ago · Quiver AI Summary. UNITY Biotechnology has appointed Federico Grossi, M.D., Ph.D., as its new chief medical officer to enhance its leadership team. Dr. Grossi, who has over 20 years of experience in biotech, previously led the development of SYFOVRE for geographic atrophy at Apellis Pharmaceuticals, where he oversaw numerous clinical programs.
UNITY Biotechnology Announces Appointment of Federico Grossi…
3 days ago · UNITY Biotechnology [NASDAQ: UBX] has appointed Federico Grossi, M.D., Ph.D., as chief medical officer. Dr. Grossi brings over 20 years of biotech industry experience, most recently serving as CMO at Apellis Pharmaceuticals where he led the development of SYFOVRE for geographic atrophy. ... UBX Latest News. Nov 4, 2024. UNITY Biotechnology, Inc ...
UNITY Biotechnology Announces Appointment of Federico Grossi…
SAN FRANCISCO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [ UBX], a biotechnology company developing therapeutics to slow, halt or reverse diseases of aging, today strengthened the executive leadership team with the appointment of Federico Grossi, M.D., Ph.D., as chief medical officer.
- Some results have been removed